Beating Blood Sugar Together

I have been a nurse for forty-one years. I retired in 2024 from a hospital in Indianapolis where I had worked the diabetic care unit since 1985. What I saw in those wards over four decades was a staircase. The same staircase repeating itself with thousands of women. I am writing this because three years ago a patient's granddaughter came back to the unit to thank me for caring for her grandmother in 2019, and what she told me at the nursing station that afternoon about why her grandmother stopped coming to her appointments has not let me sleep since. The truth she told me was buried in 1922 by the American Medical Association, by Eli Lilly's eleven point four million dollar commercial decision, and by the curriculum that trained me and every nurse who came after me. None of us were ever told. I was not told for thirty-six years. If you have been on metformin for two years or ten and your A1C has not moved, you need to read what I am about to share. Because what I learned three years ago after thirty-six years of nursing is documented medical history that was deliberately removed from my training and from yours. My name does not matter. I am writing this anonymously because I do not want my pension or my reputation tangled in what I am about to share. I will tell you who I am in terms that can be verified. I graduated from a Midwestern nursing school in 1983. I passed my boards. I began work in the diabetic care unit at a major Indianapolis hospital in 1985. I stayed in that unit for thirty-eight years. I retired in 2024 at the age of sixty-five. In forty-one years of nursing I cared for thousands of patients with Type Two diabetes. I administered tens of thousands of insulin injections. I watched patients walk into the unit on metformin alone, then come back six months later on metformin and Farxiga, then come back a year later on insulin, then come back the next year with neuropathy I had to dress, then come back the year after with vision loss I had to coordinate referrals for, then come back the year after that with foot ulcers, then come back the year after that with amputations. I watched this same staircase happen thousands of times. I assumed it was inevitable. I assumed this was just how the disease progressed. That is what every protocol I was trained on assumed. That is what every doctor I worked alongside assumed. That is what every patient was told when she sat across from her endocrinologist for her quarterly follow-up. I was wrong. We were all wrong. I want to tell you how I found out. In March 2019 I cared for a woman in our outpatient diabetic care follow-up program. Her name is not the point. She was sixty-eight when she first came to us. Her A1C was six point nine. She had been on metformin for nine years. She was scheduled to begin insulin in the spring. She did not begin insulin. She came back for her quarterly follow-up in May 2019 with an A1C of five point eight. I checked the lab three times because I assumed there had been a sample error. The endocrinologist reviewed the labs and wrote in her chart that the patient reported using a natural supplement. He did not ask which one. He did not ask about dosing. He did not ask about anything. I asked her at her next vitals check. She told me she was taking a liquid she held under her tongue each morning before her coffee. She had found it through her granddaughter's research. She did not want to discuss it further because she did not want her doctor to take her off it. I wrote down what she said on the back of an intake form and tucked it in my locker. I did not pursue it. I had been a nurse long enough to know that women in their late sixties sometimes have remissions that look miraculous and then revert within a year. She continued to come back for her quarterly follow-ups. Her A1C kept falling. By the end of 2020 her A1C was five point four. She did not return to us in 2021 or 2022 or 2023. She did not need to. In late 2022 her granddaughter walked into the unit looking for me. She had come to thank me for being kind to her grandmother during her appointments. Then she told me what her grandmother had been doing for those three years. I sat down at the nursing station and listened. What the granddaughter told me sitting at the nursing station was that her grandmother had been following a protocol her great-great-grandmother had used in Italy in 1879. Her great-great-grandmother had been a patient of an Italian physician named Arnaldo Cantani at the University of Naples Medical School. Cantani had treated her great-great-grandmother with what he called saccharine diabetes therapy. The protocol was three bitter plants taken sublingually each morning. Goldenseal. Oregon grape root. Barberry. The family had carried the original recipe and the original method through five generations and across the Atlantic Ocean to Indianapolis. The granddaughter pulled out her phone and showed me a 2015 study from Beijing University of Chinese Medicine published in PLOS ONE. One hundred and eighty-four patients. Sublingual berberine extract, the active compound in the three plants Cantani used. Fifty-two percent reduction in hepatic fat confirmed via MRI imaging. Normalized fasting glucose within twelve weeks. Cited twenty-three hundred times in peer-reviewed literature since publication. She then told me what she had learned about why I had never heard Cantani's name in nursing school. Cantani's protocol was used throughout Europe for forty-six years. In January nineteen twenty-two, Banting and Best isolated insulin at the University of Toronto. In October nineteen twenty-three, Eli Lilly invested eleven point four million dollars in insulin mass production. Between nineteen twenty-three and nineteen twenty-five the Rockefeller Foundation funded the insulin research expansion that extended injectable therapy from Type One diabetes, which represented about ten percent of the diabetic population, to Type Two diabetes as well. The other ninety percent. The patients whose bodies still produced insulin but whose livers had lost regulatory function. The patients Cantani had been successfully treating for forty-six years. By nineteen thirty-five Cantani's textbook was out of print. By nineteen fifty-five his name was absent from American endocrinology and nursing curricula at every major institution. By nineteen eighty-three I graduated from nursing school without ever hearing his name. The granddaughter said: he was not wrong. He was inconvenient. I sat at the nursing station and could not respond for several minutes. I had administered tens of thousands of insulin injections to women whose grandmothers and great-grandmothers should have had access to a different protocol that had worked. What I learned over the next six months from following up on what the granddaughter told me has changed how I understand four decades of patient care. Type Two diabetes is not a pancreas disease. It is a liver disease. In a healthy adult the liver maintains tight regulation of glucose release into the bloodstream particularly between three and five AM. In a prediabetic adult the liver loses this regulatory function and quietly releases glucose into the bloodstream while the patient sleeps. The patient wakes with fasting glucose twenty to forty points higher than it should be despite having eaten nothing since dinner. I have charted this pattern thousands of times. I have watched patients track their fasting glucose readings climbing on apps. I have administered fasting blood draws at six AM for forty years. I have never been taught why the dawn elevation happens. The Karolinska Institute in Stockholm published the answer in 2019. The enzyme responsible is AMP-activated protein kinase. AMPK. AMPK is the master switch in the liver that regulates overnight glucose release. In a healthy person it stays active overnight. In a prediabetic person it deactivates around three AM. The Karolinska researchers called it the Dawn Switch. Berberine activates AMPK. That is the compound in the three plants Cantani used in 1879. That is the compound the 2015 Beijing study confirmed biochemically. That is the compound my patient's great-great-grandmother had been using in Naples one hundred and forty years before I administered her great-great-granddaughter's first metformin dose. I almost cried when I traced this lineage out on paper in my retirement. Forty-one years of nursing. Tens of thousands of insulin injections. Thousands of staircases watched. And the answer was published in eighteen seventy-six. I was not taught it. I was not told. None of the doctors I worked alongside were taught it either. We were all standing inside the system that buried it, never knowing what we were missing. The endocrinologists I worked alongside for thirty-eight years are not bad people. They are not evil. They are not corrupt. They were trained on the same curriculum I was. That curriculum was built around the commercial decision Eli Lilly made in October nineteen twenty-three. None of them have read Cantani. Most of them have never heard his name. This is not their fault. It is also, verifiably, by one hundred and fifty years of historical evidence and twenty-three hundred citations in peer-reviewed literature, not what works. The reason capsule berberine, the kind sold at every American vitamin store, does not work for the women who try it is delivery. Capsule berberine loses approximately ninety-nine percent of its bioavailability during gastric transit. By the time the capsule dissolves through the stomach and enters the small intestine the therapeutic concentration is gone. Stomach acid destroys most of it before it can reach the liver. This is why every patient who told me over the years that she had tried berberine had no measurable result on her A1C. The compound was right. The delivery was wrong. I had been telling patients politely for thirty-something years that supplements were unlikely to help when in fact one specific delivery of one specific compound had been the standard of care in Europe for forty-six years before I was born. Cantani knew this empirically in 1879. He instructed his Naples patients to hold the bitter extract under the tongue rather than swallow it directly. He observed that swallowed extract did not produce the same effect as extract held under the tongue. The 2015 Beijing team confirmed the biochemistry of this observation using modern absorption assays. Sublingual extract absorbs through the sublingual capillary network. It reaches systemic circulation in approximately ninety seconds. It bypasses gastric transit entirely. It reaches the liver at therapeutic concentration. Same compound. Different delivery. The difference between berberine doesn't work for me and watching the dawn phenomenon disappear from a patient's CGM between three and five AM. I had been giving the wrong information for decades. The protocol available now contains ten plants delivered through sublingual extract at the dosages confirmed by the 2015 Beijing study. Goldenseal. The North American root my patient's family substituted when they immigrated from Italy. Oregon grape root. The Pacific Northwest plant that shares the same active compound family. Barberry. The European shrub that gave berberine its name. Ceylon cinnamon. The species used in traditional medicine across three continents for the same therapeutic purpose. Bitter melon. The vegetable used in traditional Indian, Filipino, and Chinese diabetes therapy for centuries. Chromium. The trace mineral the body requires to maintain insulin sensitivity at the cellular level. Turmeric. With the black pepper that increases its bioavailability twenty-fold. Gymnema. The Sanskrit name translates to destroyer of sugar. Panax ginseng. For the energy stability the protocol delivers within the first two weeks. Black pepper. The carrier that ensures the rest of the formulation absorbs at full strength. Ten plants. One dropper. Held under the tongue for ninety seconds each morning before coffee. That is the protocol. It is the protocol I administered nothing like in forty-one years of nursing. The protocol I am describing exists as a current commercial product with 1,503 verified five-star reviews on the manufacturer's site. Most reviewers are women between fifty-five and seventy. Most had tried capsule berberine first and seen no measurable change. Most had been on metformin for two to ten years with A1C numbers that refused to move. The Karolinska Institute in Stockholm is one of the most respected medical research institutions in the world. They award the Nobel Prize in Physiology or Medicine. Their 2019 AMPK paper is freely accessible on PubMed. The Beijing PLOS ONE 2015 study is freely accessible online. The Newcastle DiRECT trial confirming hepatic fat reversal is freely accessible in The Lancet. Every claim in this article can be verified by anyone on a phone in the next ten minutes. You may attempt to assemble this protocol from individual capsules at any American vitamin store. The total cost runs approximately 240 dollars across nine bottles. Every one of them in capsule form. Every one of them losing ninety-nine percent of the dose to gastric transit. You may also order goldenseal tincture, Oregon grape tincture, and barberry tincture individually from naturopathic suppliers. The total runs approximately 180 dollars across three bottles. The active compounds reach therapeutic concentration through sublingual delivery, but you have to time three separate doses each morning and manage the formulation ratios yourself. The commercial product currently available is the first modern formulation that combines all ten ingredients in one dropper at the dosages the 2015 Beijing protocol used. It is the closest available modern equivalent to what Cantani prescribed in 1879. In early 2023, six months after my conversation with the granddaughter at the nursing station, I made a list of three of my former patients whose A1Cs had been climbing on metformin for years without resolution. I am not at liberty to share their names. I asked their permission before I called them. Two were still alive. One had passed in late 2022 from cardiovascular complications. The two who were alive agreed to try the sublingual protocol I described to them. I shared with them what I had learned. I made no promises. I told them the same thing I would tell you. The compound has been confirmed by modern peer-reviewed research. The delivery is what makes the difference. The first woman was seventy-one. Her A1C had been six point eight for three years on metformin ER. She began the sublingual protocol in March 2023. At thirty days her A1C was six point three. At ninety days it was five point seven. The second woman was sixty-four. Her A1C had been seven point one. She began the sublingual protocol in April 2023. At thirty days her A1C was six point four. At ninety days it was five point nine. Neither woman has been back to her endocrinologist for an A1C draw in over a year. Both of them continue the protocol every morning. Both of them have told me in our quarterly check-ins that they wish I had known about this when I was still working. So do I. If you have been on metformin for two years or ten and your A1C has not moved. If your endocrinologist has used the phrase we may want to add a second medication at your most recent appointment. If you have tried capsule berberine from Amazon or a vitamin shop and seen no result. If you have a grandmother or mother who walked the staircase I watched thousands of women walk between 1985 and 2024. If you have a granddaughter who is going to ask you in twenty years what you did when you knew. This is what was yours before nineteen twenty-three. It was yours before Eli Lilly's eleven point four million dollar commercial decision. It was yours before the AMA campaign that erased it from American medical curricula. It was yours before the Flexner Report closed the schools that taught it. It was yours before the nursing school that trained me in 1983 left it out of my curriculum. It is yours again now. I want to tell you why I am writing this anonymously and why I am writing this at all. I am writing it anonymously because I worked in the system for thirty-eight years and the institutions I worked inside still have my pension and still have my reputation. If they identify me, my standing in the nursing community will be questioned. I am not afraid of that. I am writing anonymously to protect the patients I still talk to in retirement from being treated as targets if anyone connects them to me. I am writing this at all because I cannot carry it anymore. Tens of thousands of insulin injections. Thousands of staircases watched. One protocol I did not know existed. I will live with that for whatever years I have left. What I can do now is share what I learned three years ago at a nursing station from a granddaughter who came back to thank me. That is what this article is. The truth came to me late. I am giving it to you early. The bottle is available directly from the manufacturer through the link below. Buy 2 Get 1 Free is the bundle most women start on because it covers the 90 days the Beijing study used to establish efficacy. There is a 60-day money-back guarantee. If your fasting glucose has not moved in 60 days, you email the manufacturer and they refund every dollar. No questions. No phone call. No retention specialist trying to talk you out of the refund. That is consumer protection your endocrinologist's prescription does not offer. Especially if you have already tried capsule berberine and concluded berberine does not work for your body. The compound was right. The delivery was wrong. The 2015 Beijing study proved this with double-blind data on 184 patients. The current sublingual protocol delivers the compound the way Cantani delivered it in 1879 and the way the granddaughter's great-great-grandmother delivered it in Naples to her own grandmother before that. What Arnaldo Cantani identified in eighteen seventy-six has been buried for one hundred and three years. It was yours before it was buried. You should have it back. P.S. The granddaughter still comes back to the unit twice a year to drop off baked goods for the nurses. Her grandmother is still alive at seventy-five. Her A1C at her most recent annual draw last month was five point three. She has not seen her endocrinologist since 2021. The granddaughter told me last month that her grandmother makes the protocol now for her own sister who was diagnosed with prediabetes in 2024. The protocol from 1879 has now reached its seventh generation in this family. I am sharing it with you because I do not have a family to pass it to and forty-one years of nursing did not give me the chance to share it with the patients I lost along the way.